Founder and Principal Consultant at 1st Line Partners.
Caveat Emptor in the Gray Market
Counterfeit drugs infiltrating the US pharma supply chain through gray market channels underscore the urgent need for vigilance.
Raising the Alarm
Healthcare providers must enhance awareness of counterfeit medicines to protect patients, especially as online drug purchases rise.
What Your Data Can Tell You About Illicit Trade Risk
Why taking proactive steps—and combing the right data sources—is critical to informed decision-making in risk management.
Welcome to the 'Dark Side'
Introducing a new Pharma Commerce column focused on combating illicit trade and protecting product integrity—and ultimately patients.